Archive explorer

Browse & search snapshots

Important note

Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.

For background on coverage and capture methods, see Methods & coverage.

Browse archived sites

Browse all sources →

Archived - 2018 NACI Update on Herpes Zoster Vaccines Download this article as a PDF Published by: The Public Health Agency of Canada Issue: Volume 44-9: Respiratory infections Date published: September 6, 2018 ISSN: 1481-8531 Subscribe to CCDR Submit your manuscript Information…

Archived - NACI Statement on use of Hepatitis A vaccine - Canada.ca

Public Health Agency of CanadaCaptures 114Latest capture Mar 11, 2026en

Archived - NACI Statement on use of Hepatitis A vaccine Download this article as a PDF (97 KB - 2 pages) Published by: The Public Health Agency of Canada Issue: Volume 42-9: Scientific writing Date published: September 1, 2016 ISSN: 1481-8531 Subscribe to CCDR Submit your…

Archived - NACI Update on Hepatitis B Vaccine - Canada.ca

Public Health Agency of CanadaCaptures 112Latest capture Mar 11, 2026en

Archived - NACI Update on Hepatitis B Vaccine Download this article as a PDF (417 KB - 3 pages) Published by: The Public Health Agency of Canada Issue: Volume 43-5: Implementation science Date published: May 4, 2017 ISSN: 1481-8531 Subscribe to CCDR Submit your manuscript…

Archived 19: National Advisory Committee on Immunization (NACI) rapid response: Additional dose of COVID-19 vaccine in immunocompromised individuals following 1- or 2- dose primary series [2021-09-10] Notice to reader This is an archived version. Please refer to current COVID-19…

Archived 20: Summary of National Advisory Committee on Immunization (NACI) rapid response: Booster dose of COVID-19 vaccine in long-term care residents and seniors living in other congregate settings Notice to reader This is an archived version. Please refer to current COVID-19…

Archived 24: Summary of National Advisory Committee on Immunization (NACI) statement: Recommendation on the use of the Pfizer-BioNTech COVID-19 vaccine (10 mcg) in children 5 to 11 years of age [2021-11-19] Publication date: November 19, 2021 Notice to reader This is an archived…

Archived 31: Summary of the NACI rapid response of January 28, 2022: Guidance on the use of booster COVID-19 vaccine doses in adolescents 12 to 17 years of age Notice to reader This is an archived version. Please refer to current COVID-19 vaccine pages: NACI statements and…

Archived 35: Summary of NACI statement of March 17, 2022: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age Notice to reader This is an archived version. Please refer to current COVID-19 vaccine pages: NACI statements and…

Archived 34: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz) [2022-03-11] Notice to reader This is an archived version. Please refer to current COVID-19 vaccine pages: NACI statements and publications COVID-19 vaccine: Canadian Immunization Guide Publication:…

Archived 48: Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration [December 9, 2022] Download in PDF format (1.56 MB, 25 pages) Organization: Public Health Agency of Canada Cat.:…

Page 1472 of 1582Showing 14711-14720 of 15815

Early release: coverage is bounded to the current corpus, and features may change.